|
Market Closed -
Nasdaq
15:57:30 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 213.38 USD | -0.14% |
|
+0.30% | +16.83% |
| 08-12 | UBS Adjusts Price Target on Axsome Therapeutics to $280 From $259, Keeps Buy Rating | MT |
| 08-12 | Mizuho Adjusts PT on Axsome Therapeutics to $316 From $306, Keeps Outperform Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.14% | +0.30% | -9.98% | -6.30% | +16.83% | +95.37% | +202.57% | +905.54% | +2,814.96% | 11.19B | |
| -0.31% | +2.44% | +18.34% | +15.07% | +4.10% | +38.43% | +0.77% | +27.82% | +94.25% | 80.23B | |
| -1.02% | -0.51% | +10.89% | +9.09% | -8.67% | -2.54% | +28.91% | +2.42% | - | 50.64B | |
| -3.10% | -4.84% | -10.69% | -10.42% | -11.02% | +10.29% | +160.49% | +116.02% | +191.58% | 46.87B | |
| -0.42% | +1.06% | +10.19% | +41.23% | -21.29% | -49.92% | -49.60% | -54.39% | +22.60% | 46.34B | |
| -0.39% | +0.91% | +0.44% | +8.75% | +19.23% | +51.39% | -20.90% | -38.91% | -33.05% | 31B | |
| -0.52% | +7.01% | +0.27% | +29.12% | +114.72% | +125.98% | -35.99% | -83.06% | - | 25.28B | |
| -0.30% | -0.33% | +3.01% | +26.07% | +21.66% | +38.24% | +85.63% | +62.40% | +54.34% | 24.36B | |
| +3.41% | -0.31% | +9.05% | +20.80% | +27.21% | -4.81% | +196.64% | +35.95% | - | 20.81B | |
| -1.83% | -2.82% | -5.45% | -0.14% | +32.33% | +60.85% | +109.32% | +148.95% | +333.89% | 16.08B | |
| -1.66% | -5.47% | -0.55% | +20.76% | +4.41% | +55.61% | +167.99% | +61.40% | - | 15.61B | |
| -1.10% | +2.95% | +47.63% | +10.62% | -9.19% | -6.59% | +789.32% | +503.25% | +6,261.56% | 15.47B | |
| -1.71% | +5.56% | +12.27% | +30.01% | +13.34% | +17.07% | -25.16% | -10.31% | -26.58% | 13.04B | |
| +1.20% | +1.78% | -2.79% | +8.48% | +34.77% | +121.12% | +172.35% | +515.54% | - | 9.83B | |
| -5.36% | +2.51% | +29.97% | +141.14% | +273.80% | +321.66% | +514.03% | +23.98% | - | 7.44B | |
| -2.86% | -3.10% | +7.97% | +8.45% | -7.85% | -21.09% | -26.91% | -51.62% | -49.38% | 6.86B | |
| -3.23% | +7.59% | +8.04% | +32.61% | +10.15% | +19.97% | +80.20% | -2.90% | - | 6.62B | |
| +1.72% | +3.09% | -5.25% | +5.41% | +17.81% | +35.14% | +273.30% | +248.98% | - | 6.43B | |
| -1.39% | +0.91% | +25.59% | +35.82% | +86.06% | +129.93% | +367.13% | +552.64% | - | 5.99B | |
| -2.46% | -1.41% | +0.67% | -23.91% | -33.02% | -44.93% | -50.60% | -76.34% | - | 5.64B | |
| Average | -0.98% | +0.97% | +7.48% | +20.13% | +29.27% | +49.56% | +146.98% | +144.37% | +966.42% | 22.29B | |
| Weighted average by Cap. | -0.83% | +0.75% | +7.61% | +16.81% | +14.85% | +31.61% | +88.46% | +77.91% | +517.87% |
- Stock Market
- Stocks
- AXSM Stock
- Sector Axsome Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
